Please use this identifier to cite or link to this item:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agents

AuthorsKlug, Dana M.; Díaz-González, Rosario; Pérez-Moreno, Guiomar; Ceballos-Pérez, Gloria; García-Hernández, Raquel; Gómez-Pérez, Veronica; Ruiz-Pérez, Luis Miguel; Rojas-Barros, Domingo I.; Gamarro, Francisco; González-Pacanowska, D.; Martínez-Martínez, María S.; Manzano, Pilar; Ferrins, Lori; Caffrey, Conor R.; Navarro, M.; Pollastri, M.P.
Issue Date8-Feb-2019
PublisherPublic Library of Science
CitationPLoS Neglected Tropical Diseases
AbstractNew treatments are needed for neglected tropical diseases (NTDs) such as Human African trypanosomiasis (HAT), Chagas disease, and schistosomiasis. Through a whole organism high-throughput screening campaign, we previously identified 797 human kinase inhibitors that grouped into 59 structural clusters and showed activity against T. brucei, the causative agent of HAT. We herein report the results of further investigation of one of these clusters consisting of substituted isatin derivatives, focusing on establishing structure-activity and -property relationship scope. We also describe their in vitro absorption, distribution, metabolism, and excretion (ADME) properties. For one isatin, NEU-4391, which offered the best activity-property profile, pharmacokinetic parameters were measured in mice.
Publisher version (URL)
DOI10.1371/journal. pntd.0007129
Appears in Collections:(IPBLN) Artículos

Files in This Item:
File Description SizeFormat
Klug-2019-Evaluation-of-a-class-of-isatinoids.pdfResearch article1,14 MBAdobe PDFThumbnail
Show full item record
Review this work

Google ScholarTM




WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.